Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 10/20 | 0.66 |
| ▸ | MAOB | P27338 | 9/20 | 0.66 |
| ▸ | DHODH | Q02127 | 6/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25614244 | 0.89 | DHODH (0.76) | DHODHMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL20956524 | 0.89 | DHODH (0.80) | MAOAMAOBDHODHRAB9ANPC1 | |
| SCHEMBL29911542 | 0.89 | DHODH (0.80) | MAOAMAOBDHODHRAB9ANPC1 | |
| SCHEMBL19631420 | 0.89 | DHODH (0.80) | MAOAMAOBDHODHRAB9ANPC1 | |
| SCHEMBL25614217 | 0.88 | DHODH (0.63) | MAOAMAOBDHODHMEN1MAPT | |
| SCHEMBL25614468 | 0.88 | DHODH (0.68) | MAOAMAOBDHODHMEN1MAPT | |
| SCHEMBL25613879 | 0.81 | MAOA (0.71) | MAOAMAOB | |
| SCHEMBL20956540 | 0.80 | DHODH (0.76) | MAOAMAOBDHODHMEN1MAPT | |
| SCHEMBL19631476 | 0.80 | DHODH (0.76) | MAOAMAOBDHODHMEN1MAPT | |
| SCHEMBL25614473 | 0.80 | DHODH (0.69) | DHODHMEN1MAPTKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190713-A1 | ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190713-A1 | ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF | SARS1, EIF2AK2, NSUN3 | MAOA 4585/4885MAOB 4626/4885DHODH 2268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.